Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022

SELL
$41.2 - $73.6 $5.17 Million - $9.24 Million
-125,497 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$59.15 - $91.99 $3.31 Million - $5.14 Million
55,919 Added 80.37%
125,497 $7.95 Million
Q2 2021

Aug 04, 2021

BUY
$63.02 - $95.11 $4.38 Million - $6.62 Million
69,578 New
69,578 $6.37 Million
Q3 2019

Nov 12, 2019

SELL
$20.03 - $40.08 $1.06 Million - $2.11 Million
-52,732 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$25.78 - $39.77 $36,478 - $56,274
1,415 Added 2.76%
52,732 $1.9 Million
Q1 2019

May 03, 2019

BUY
$22.09 - $39.21 $1.13 Million - $2.01 Million
51,317 New
51,317 $1.62 Million
Q4 2018

Feb 12, 2019

SELL
$19.89 - $30.02 $2.34 Million - $3.53 Million
-117,526 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$12.1 - $28.85 $1.42 Million - $3.39 Million
117,526 New
117,526 $3.39 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.25B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.